- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03896334
Effect of Isometric Handgrip Training on Ambulatory Blood Pressure in Patients With Hypertension (ISOPRESS)
May 7, 2024 updated by: Aline Mendes Gerage, Universidade Federal de Santa Catarina
Effect of Isometric Handgrip Training on Ambulatory Blood Pressure: a Multi-center Study
Meta-analysis studies have demonstrated that isometric training with handgrip promotes reductions in clinical blood pressure, reaching 8 mmHg for systolic blood pressure and 4 mmHg for diastolic.
However, the effects of this training modality on ambulatory blood pressure, which is better discriminant of cardiovascular risk than clinical BP, remains uncertain.
Thus, the ISOPRESS Network, consists of researchers from Brazilian institutions of education and research (Federal University of Santa Catarina, Federal University of Amazonas, Federal University of Sergipe, Federal Rural University of Pernambuco and Universidade Nove de Julho), will conduct a multi-center study to analyze the effects of isometric handgrip training on clinic and 24-h ambulatory blood pressure in patients with hypertension.
For this, each research center will conduct a randomized controlled trial with medicated patients with hypertension, of both sex.
The participants will be randomized into two groups: isometric handgrip training group (HBT: n = 25 per center) and control group (CG: n = 25 per center).Subjects assigned to the HBT will train three times per week, four sets of 2-min isometric contractions (using alternate hands) at 30% of maximal voluntary contraction, during 24 weeks.
Subjects randomized to the CG will perform stretching and relaxation exercises three times per week, during 24 weeks.
The evaluations will occur in three moments: baseline, post-12 and post-24 weeks.
The primary outcome will be ambulatory blood pressure, while clinic blood pressure and cardiac autonomic modulation will be analyzed as secondary outcomes.
For data analysis, in addition to descriptive statistics, two-way ANOVA for mixed model will be applied for within and between groups comparison.
The level of significance that will be adopted is p<0.05.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aline Gerage, PhD
- Phone Number: 554837218554
- Email: alinegerage@yahoo.com.br
Study Locations
-
-
-
Aracaju, Brazil
- Recruiting
- Federal University of Sergipe
-
Contact:
- Aluísio Lima, PhD
-
Parintins, Brazil
- Not yet recruiting
- Federal University of Amazonas
-
Contact:
- Wagner Domingues, PhD
-
Recife, Brazil
- Recruiting
- Federal Rural University of Pernambuco
-
Contact:
- Breno Q Farah, PhD
-
São Paulo, Brazil
- Recruiting
- Universidade Nove de Julho
-
Contact:
- Raphael M Ritti-Dias, PhD
-
-
Santa Catarina
-
Florianopolis, Santa Catarina, Brazil, 88040-900
- Not yet recruiting
- Universidade Federal de Santa Catarina
-
Contact:
- ALINE M GERAGE, PhD
- Phone Number: 4899934799
- Email: alinegerage@yahoo.com.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of hypertension, controlled by up to three antihypertensive medications
- Blood pressure levels between 130 and 180 mmHg
- No high cardiovascular risk (no other cardiovascular, metabolic or pulmonary disease nor any signals or symptoms of these disease)
- Not engaged in a physical exercise program for at least six months
- Not present cognitive impairment (Montreal Cognitive Assessment ≥ 26 points)
Exclusion Criteria:
- Adherence to less than 85% of training sessions
- Diagnosis of other cardiovascular diseases or diabetes during the course of the study
- Adherence to another supervised physical exercise program
- Change in medication class and/ or dose during the study
- Aggravation of the disease (i.e. blood pressure above 180 or use of four or more medications).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Isometric handgrip training
All participants that will be assigned to supervised isometric handgrip training will train three times per week, during 24 weeks.
They will perform a bout of isometric handgrip exercise: four sets of 2-min of isometric contractions (using alternate hands) at 30% of maximal voluntary contraction.
|
The participants randomized to the experimental group will perform 24 weeks of isometric handgrip exercise training, three times/week for 16 minutes with time to rest.
|
Sham Comparator: Control group
All participants randomized to control group will realize stretching and relaxation exercises, three times per week, during 24 weeks.
|
The participants randomized to the control group (active comparator) will perform 24 weeks of stretching and relaxation exercise training, three times/week for 16 minutes with time to rest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in ambulatory systolic blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
24h-ambulatory blood pressure monitoring
|
Baseline, 12 weeks 24 weeks
|
Change in ambulatory diastolic blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
24h-ambulatory blood pressure monitoring
|
Baseline, 12 weeks 24 weeks
|
Change in ambulatory mean blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
24h-ambulatory blood pressure monitoring
|
Baseline, 12 weeks 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in clinic systolic blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
Clinic blood pressure will be checked using an automatic instrument
|
Baseline, 12 weeks 24 weeks
|
Change in clinic diastolic blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
Clinic blood pressure will be checked using an automatic instrument
|
Baseline, 12 weeks 24 weeks
|
Change in clinic mean blood pressure
Time Frame: Baseline, 12 weeks 24 weeks
|
Clinic blood pressure will be checked using an automatic instrument
|
Baseline, 12 weeks 24 weeks
|
Change in heart rate variability
Time Frame: Baseline, 12 weeks 24 weeks
|
For heart rate variability assessment, R-R interval will be obtained using a heart rate monitor (POLAR, RS 800CX), following the recommendations of the Task Force of the European Society of Cardiology and the North American.
|
Baseline, 12 weeks 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 5, 2019
Primary Completion (Estimated)
July 15, 2024
Study Completion (Estimated)
December 15, 2024
Study Registration Dates
First Submitted
March 28, 2019
First Submitted That Met QC Criteria
March 28, 2019
First Posted (Actual)
March 29, 2019
Study Record Updates
Last Update Posted (Actual)
May 9, 2024
Last Update Submitted That Met QC Criteria
May 7, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISOPRESS_MULTICENTER STUDY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
Clinical Trials on Supervised Isometric Handgrip Training
-
University of Massachusetts, BostonNot yet recruiting
-
University of PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompleted
-
University of PernambucoFundação de Amparo à Pesquisa do Estado de São PauloCompletedPeripheral Artery DiseaseBrazil
-
University of Nove de JulhoHospital Israelita Albert EinsteinRecruitingPeripheral Arterial DiseaseBrazil
-
KU LeuvenResearch Foundation FlandersCompleted
-
University Institute of MaiaUniversity of Connecticut; Aveiro University; Hospital Infante D. Pedro, Centro... and other collaboratorsCompletedHypertension | Pre-HypertensionUnited States, Portugal
-
University of NottinghamThe Royal College of Surgeons of England; The Dunhill Medical TrustUnknownHypertension | Perioperative HypertensionUnited Kingdom
-
Instituto de Cardiologia do Rio Grande do SulRecruitingArterial HypertensionBrazil
-
Riphah International UniversityRecruitingHealthy AdolescentsPakistan
-
Swansea UniversityNational Taiwan Normal UniversityRecruitingBlood PressureTaiwan, United Kingdom